Effects of Etanercept Are Distinct from Infliximab in Modulating Proinflammatory Genes in Activated Human Leukocytes

This publication has 21 references indexed in Scilit:

• Genomic Analysis Defines a Cancer-Specific Gene Expression Signature for Human Squamous Cell Carcinoma and Distinguishes Malignant Hyperproliferation from Benign Hyperplasia
  Journal of Investigative Dermatology, 2006
• Psoriasis: emerging therapeutic strategies
  Nature Reviews Drug Discovery, 2005
• The influence of genetic variation in the HLA–DRB1 and LTA–TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept
  Arthritis & Rheumatism, 2004
• Critical Role of Interleukin-1β for Transcriptional Regulation of Endothelial 6-Pyruvoyltetrahydropterin Synthase
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
• TGF-β/Smad signaling inhibits IFN-γ and TNF-α-induced TARC (CCL17) production in HaCaT cells
  Journal of Dermatological Science, 2003
• Differential chemokine expression profiles in human peripheral blood T lymphocytes: dependence on T-cell coreceptor and calcineurin signaling
  Blood, 2003
• Preferential expression of Th2-type chemokine and its receptor in atopic dermatitis
  International Immunology, 2002
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001
• Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
  Molecular Immunology, 1993
• Molecular cloning and expression of a receptor for human tumor necrosis factor
  Cell, 1990